420
Views
0
CrossRef citations to date
0
Altmetric
Corrigenda

Corrigendum

This article refers to:
A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States

Nuijten, M., Marczewska, A., Araujo Torres, K., Rasouli, B., Perugini, M. (2018). A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States. J Med Econ. 2018.

https://doi.org/10.1080/13696998.2018.1468334

When the above article was first published online, there were errors in the corresponding author’s affiliation, the reference list and the in-text reference citations.

The correct affiliation for the corresponding author is “Ars Accessus Medica”. This has now been amended on the published article.

The correct reference 37 is as follows:

37. Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized controlled trial of 3.0 mg liraglutide in weight management. N Engl J Med 2015;373:11-22.

This reference has been inserted into the reference list as reference 37, and subsequent references have been renumbered.

The in-text reference citations have been renumbered throughout the published article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.